J
João Conde
Researcher at Universidade Nova de Lisboa
Publications - 114
Citations - 6597
João Conde is an academic researcher from Universidade Nova de Lisboa. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 35, co-authored 94 publications receiving 4797 citations. Previous affiliations of João Conde include University of Lisbon & Massachusetts Institute of Technology.
Papers
More filters
Journal ArticleDOI
Noble metal nanoparticles for biosensing applications.
Gonçalo Doria,João Conde,Bruno Veigas,Letícia Giestas,Carina Almeida,Maria Assunção,João Rosa,Pedro V. Baptista +7 more
TL;DR: The use of noble metal nanoparticles for biosensing strategies is reviewed—from synthesis and functionalization to integration in molecular diagnostics platforms, with special focus on those that have made their way into the diagnostics laboratory.
Journal ArticleDOI
Noble metal nanoparticles applications in cancer.
TL;DR: Here, a review of the available noble metal nanoparticles for cancer therapy is reviewed, with particular focus on those already being translated into clinical settings.
Journal ArticleDOI
Local triple-combination therapy results in tumour regression and prevents recurrence in a colon cancer model
TL;DR: It is demonstrated that the combination of gene, drug and phototherapy delivered through a prophylactic hydrogel patch leads to complete tumour remission when applied to non-resected tumours and to the absence of tumour recurrence when applied following tumour resection.
Journal ArticleDOI
Revisiting 30 years of biofunctionalization and surface chemistry of inorganic nanoparticles for nanomedicine
João Conde,Jorge Dias,Valeria Grazú,María Moros,Pedro V. Baptista,Jesús M. de la Fuente,Jesús M. de la Fuente +6 more
TL;DR: The aim of this review is not only to provide in-depth insights into the different biofunctionalization and characterization methods, but also to give an overview of possibilities and limitations of the available nanoparticles.
Journal ArticleDOI
Nanotechnology-based disinfectants and sensors for SARS-CoV-2.
TL;DR: Nanotechnology-based antimicrobial and antiviral formulations can prevent SARS-CoV-2 viral dissemination, and highly sensitive biosensors and detection platforms may contribute to the detection and diagnosis of COVID-19.